Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation
- PMID: 32764526
- PMCID: PMC7460658
- DOI: 10.3390/ijms21165619
Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation
Abstract
Antimicrobial resistance is an important issue for global health; in immunocompromised patients, such as solid organ and hematological transplant recipients, it poses an even bigger threat. Colonization by multidrug-resistant (MDR) bacteria was acknowledged as a strong risk factor to subsequent infections, especially in individuals with a compromised immune system. A growing pile of studies has linked the imbalance caused by the dominance of certain taxa populating the gut, also known as intestinal microbiota dysbiosis, to an increased risk of MDR bacteria colonization. Several attempts were proposed to modulate the gut microbiota. Particularly, fecal microbiota transplantation (FMT) was successfully applied to treat conditions like Clostridioides difficile infection and other diseases linked to gut microbiota dysbiosis. In this review we aimed to provide a look at the data gathered so far on FMT, focusing on its possible role in treating MDR colonization in the setting of immunocompromised patients and analyzing its efficacy and safety.
Keywords: antimicrobial resistance; decolonization; dysbiosis; fecal microbiota transplantation; gut colonization; gut microbiota; immunocompromised; multidrug-resistant.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Cassini A., Högberg L.D., Plachouras D., Quattrocchi A., Hoxha A., Simonsen G.S., Colomb-Cotinat M., Kretzschmar M.E., Devleesschauwer B., Cecchini M., et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 2018;19:56–66. doi: 10.1016/S1473-3099(18)30605-4. - DOI - PMC - PubMed
-
- Magiorakos A.-P., Srinivasan A., Carey R., Carmeli Y., Falagas M.E., Giske C., Harbarth S., Hindler J., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x. - DOI - PubMed
-
- European Centre for Disease Prevention and Control . Surveillance of Antimicrobial Resistance in Europe. ECDC; Stockholm, Sweden: 2018. 2019.
-
- European Centre for Disease Prevention and Control . Carbapenem-Resistant Enterobacteriaceae Second Update. ECDC; Stockholm, Sweden: 2019. 26 September 2019.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
